Cathepsins B and X are lysosomal
cysteine carboxypeptidases suggested as having a redundant role in
cancer. They are involved in a number of processes leading to
tumor progression but their role in the epithelial-mesenchymal transition (EMT) remains unknown. We have investigated the contribution of both
cathepsins B and X in EMT using tumor cell lines differing in their expression of epithelial and mesenchymal markers and cell morphology. Higher levels of both
cathepsins are shown to promote EMT and are associated with the mesenchymal-like cell phenotype. Moreover, simultaneous knockdown of the two
peptidases triggers a reverse, mesenchymal to epithelial transition. Of the two
cathepsins,
cathepsin B appears to be the stronger promotor of EMT. Furthermore, we evaluated the involvement of
cathepsin B and X in the transforming growth factor-β1 (TGF-β1) signaling pathway, one of the key signaling mechanisms triggering EMT in
cancer. In MCF-7 cells the expression of
cathepsin B was shown to depend on their activation with TGF-β1 while, for
cathepsin X, a TGF-β1 independent mechanism of induction during EMT is indicated. EMT is thus shown to be another mechanism linking
cathepsins B and X with
tumor progression. With silencing of their expression or inhibition of enzymatic activity, the
tumor cells could be reverted to less aggressive epithelial-like phenotype.